Global Deoxyribonucleic Acid (DNA) Sequencing In Drug Discovery Market Report 2026–2035: Key Forecasts and Growth Areas
Uncover key drivers, emerging technologies, and competitive movements shaping the deoxyribonucleic acid (dna) sequencing in drug discovery market from 2026–2035 with trusted insights from The Business Research Company
What market expansion outlook does the Deoxyribonucleic Acid (DNA) Sequencing In Drug Discovery Market show for the 2026–2030 period?
The deoxyribonucleic acid (dna) sequencing in drug discovery market has seen substantial expansion in its size over recent years. Its valuation is anticipated to climb from $8.46 billion in 2025 to $9.49 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 12.3%. The historical increase in this market can be linked to several factors, including heightened investment in genomic research, the widening of pharmaceutical research and development (R&D) pipelines, the widespread availability of high-throughput sequencing platforms, an increasing focus on personalized medicine, and advancements in sequencing accuracy and speed.
The deoxyribonucleic acid (dna) sequencing in drug discovery market is anticipated to experience substantial growth in the coming years. It is projected to reach $15.22 billion by 2030, with a compound annual growth rate (CAGR) of 12.5%. This growth during the forecast period is attributed to the increasing adoption of AI-driven genomic analysis, a rising demand for targeted therapeutics, the expansion of pharmacogenomics applications, the growing utilization of sequencing in early-stage drug screening, and increasing collaboration between pharmaceutical and biotechnology firms. Major trends expected in the forecast period include the increasing use of next-generation sequencing in target identification, the rising adoption of single-cell sequencing approaches, the growing integration of bioinformatics in drug discovery, the expansion of precision medicine research programs, and an enhanced focus on biomarker-driven drug development.
Access Your Free Sample Report for In-Depth Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=33087&type=smp
What Drivers Are Shaping The Development Of The Deoxyribonucleic Acid (DNA) Sequencing In Drug Discovery Market?
The expanding need for personalized medicine is anticipated to drive the advancement of deoxyribonucleic acid (DNA) sequencing within the drug discovery market. Personalized medicine describes a medical strategy that adapts disease prevention, diagnosis, and treatment to a person’s genetic profile, way of life, and environmental elements. The increased interest in personalized medicine primarily stems from breakthroughs in genomics and molecular diagnostics, which allow for the accurate detection of genetic and molecular distinctions among individuals, leading to customized treatments for greater efficacy and fewer adverse reactions. Deoxyribonucleic acid (DNA) sequencing aids personalized medicine by pinpointing patient-specific genetic variations, which facilitates the creation of targeted therapies, refined drug selection, and enhanced treatment effectiveness with fewer undesirable effects. For example, in February 2024, data from the Personalized Medicine Coalition, a US-based non-profit organization, indicated that in 2023, the Food and Drug Administration (FDA) sanctioned 16 novel personalized treatments for rare disease patients, an increase from six in 2022. The new personalized treatments approved in 2023 also encompassed seven cancer drugs and three for other diseases and conditions. Consequently, the increasing demand for personalized medicine is propelling the growth of deoxyribonucleic acid (DNA) sequencing in the drug discovery market.
Which Segments Are Contributing To The Growth Of The Deoxyribonucleic Acid (DNA) Sequencing In Drug Discovery Market?
The deoxyribonucleic acid (dna) sequencing in drug discovery market covered in this report is segmented –
1) By Product Type: Instruments; Consumables
2) By Workflow: Sample Preparation; Sequencing
3) By Technology Type: Sanger Sequencing; Next-Generation Sequencing (NGS)
4) By Application: Drug Discovery; Pharmacogenomics
5) By End-User: Pharmaceutical Companies; Biotechnology Firms
Subsegments:
1) By Instruments: Sequencing Systems; Sample Preparation Systems; Detection And Imaging Systems; Automation And Robotics Systems; Data Analysis Hardware
2) By Consumables: Sequencing Reagents; Library Preparation Kits; Sample Collection Kits; Flow Cells; Quality Control Reagents
What Industry Trends Are Transforming The Deoxyribonucleic Acid (DNA) Sequencing In Drug Discovery Market?
Companies prominent in the deoxyribonucleic acid (DNA) sequencing in the drug discovery market are concentrating on creating sophisticated solutions, such as high-resolution DNA methylation sequencing assays, to advance biomarker discovery and accelerate precision drug development. These high-resolution DNA methylation sequencing assays represent advanced genomic techniques capable of accurately detailing DNA methylation at single-base or near single-base resolution throughout the genome. This capability allows for thorough examination of epigenetic modifications influencing gene activity, thereby contributing to a precise comprehension of disease biology and the identification of potential targets for drugs. As an illustration, in April 2025, the US-based epigenetics firm, EpiCypher Inc., launched CUTANA mCUT&RUN and Multiomic CUT&RUN, two novel DNA methylation sequencing assays designed to deliver high-resolution methylation profiling while significantly reducing sequencing expenses and required sample inputs. These assays empower researchers to concurrently analyze both DNA methylation and chromatin characteristics, providing more profound multiomic perspectives on gene regulation mechanisms. Ultimately, these advancements in assays support faster and more economical identification and validation of targets, thus speeding up the entire drug discovery and development process.
Who Are The Primary Competitors In The Global Deoxyribonucleic Acid (DNA) Sequencing In Drug Discovery Market?
Major companies operating in the deoxyribonucleic acid (dna) sequencing in drug discovery market are Thermo Fisher Scientific Inc., Eurofins Genomics GmbH, Agilent Technologies Inc., Illumina Inc., Revvity Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., 10x Genomics Inc., BGI Genomics, Azenta Life Sciences, Oxford Nanopore Technologies plc, Pacific Biosciences of California Inc., Element Biosciences Inc., Macrogen Inc., Ultima Genomics Inc., SOPHiA GENETICS SA, ProPhase Labs Inc., Singular Genomics Systems Inc., Psomagen Inc., and QitanTech Co Ltd.
Access The Complete Report For Deeper Market Insights:
Which Global Regions Are Shaping The Competitive Landscape Of The Deoxyribonucleic Acid (DNA) Sequencing In Drug Discovery Market?
North America was the largest region in the deoxyribonucleic acid (DNA) sequencing in drug discovery market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the deoxyribonucleic acid (dna) sequencing in drug discovery market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request Your Customized Deoxyribonucleic Acid (DNA) Sequencing In Drug Discovery Market Research Report for Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=33087&type=smp
Browse Through More Reports Similar to the Global Deoxyribonucleic Acid (DNA) Sequencing In Drug Discovery Market 2026, By The Business Research Company
Dna Sequencing Market Report 2026
https://www.thebusinessresearchcompany.com/report/dna-sequencing-global-market-report
Ribonucleic Acid Rna Sequencing Market Report 2026
Clinical Oncology Next Generation Sequencing Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
